Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions

Ariel Green, Patricia Lee, Emily Reeve, Jennifer Wolff, Chi Chiung Grace Chen, Rachel Kruzan, Cynthia Boyd

Research output: Contribution to journalArticle

Abstract

PURPOSE: Patients with dementia experience high rates of polypharmacy, potentially inappropriate medication use, and adverse drug events. There is little guidance for clinicians on how to optimize prescribing for this population. Our objective was to investigate clinician-perceived barriers to and facilitators of optimizing prescribing for people with dementia. METHODS: Qualitative study involving semistructured interviews of primary care and specialist clinicians in urban, suburban, and rural settings. Transcripts were analyzed using qualitative content analysis. RESULTS: Interviews were conducted with 12 primary care and 9 specialist clinicians, with a mean (SD) age of 47 (9) and mean (SD) of 14 (10) years in practice. Clinicians cited decisions regarding the following drug classes as particularly challenging: oral anticoagulants, antidiabetic agents, statins, bladder antimuscarinics, and antipsychotics. Perceived enablers of optimizing prescribing included access to interdisciplinary services and guidelines for nondementia illnesses (eg, diabetes) addressing the care of people with dementia. Barriers included the lack of data on efficacy and safety of most medications in people with dementia, difficulty assessing medication effects in an individual patient, and the perception that stopping medications is seen as "giving up." Clinicians used a variety of strategies to discuss risks and benefits of medications with patients and caregivers. CONCLUSIONS: Clinicians identified numerous barriers to and some facilitators of optimizing prescribing in people with dementia. More data are needed on the benefits and harms of stopping medications in this population. Research should also test different approaches for supporting informed decision making about medications by people with dementia and caregivers.

Original languageEnglish (US)
Pages (from-to)383-391
Number of pages9
JournalJournal of the American Board of Family Medicine : JABFM
Volume32
Issue number3
DOIs
StatePublished - May 1 2019

Fingerprint

Dementia
Caregivers
Primary Health Care
Interviews
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Polypharmacy
Muscarinic Antagonists
Drug-Related Side Effects and Adverse Reactions
Hypoglycemic Agents
Anticoagulants
Antipsychotic Agents
Population
Decision Making
Urinary Bladder
Guidelines
Safety
Research
Pharmaceutical Preparations

Keywords

  • Adverse Decision Making
  • Comorbidity
  • Dementia
  • Drug Reaction
  • Geriatrics
  • Polypharmacy
  • Potentially Inappropriate Medications
  • Primary Health Care
  • Qualitative Research
  • Risk Assessment

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

@article{00f4a82b86524bd79636dcac5ca45c70,
title = "Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions",
abstract = "PURPOSE: Patients with dementia experience high rates of polypharmacy, potentially inappropriate medication use, and adverse drug events. There is little guidance for clinicians on how to optimize prescribing for this population. Our objective was to investigate clinician-perceived barriers to and facilitators of optimizing prescribing for people with dementia. METHODS: Qualitative study involving semistructured interviews of primary care and specialist clinicians in urban, suburban, and rural settings. Transcripts were analyzed using qualitative content analysis. RESULTS: Interviews were conducted with 12 primary care and 9 specialist clinicians, with a mean (SD) age of 47 (9) and mean (SD) of 14 (10) years in practice. Clinicians cited decisions regarding the following drug classes as particularly challenging: oral anticoagulants, antidiabetic agents, statins, bladder antimuscarinics, and antipsychotics. Perceived enablers of optimizing prescribing included access to interdisciplinary services and guidelines for nondementia illnesses (eg, diabetes) addressing the care of people with dementia. Barriers included the lack of data on efficacy and safety of most medications in people with dementia, difficulty assessing medication effects in an individual patient, and the perception that stopping medications is seen as {"}giving up.{"} Clinicians used a variety of strategies to discuss risks and benefits of medications with patients and caregivers. CONCLUSIONS: Clinicians identified numerous barriers to and some facilitators of optimizing prescribing in people with dementia. More data are needed on the benefits and harms of stopping medications in this population. Research should also test different approaches for supporting informed decision making about medications by people with dementia and caregivers.",
keywords = "Adverse Decision Making, Comorbidity, Dementia, Drug Reaction, Geriatrics, Polypharmacy, Potentially Inappropriate Medications, Primary Health Care, Qualitative Research, Risk Assessment",
author = "Ariel Green and Patricia Lee and Emily Reeve and Jennifer Wolff and Chen, {Chi Chiung Grace} and Rachel Kruzan and Cynthia Boyd",
year = "2019",
month = "5",
day = "1",
doi = "10.3122/jabfm.2019.03.180335",
language = "English (US)",
volume = "32",
pages = "383--391",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "3",

}

TY - JOUR

T1 - Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions

AU - Green, Ariel

AU - Lee, Patricia

AU - Reeve, Emily

AU - Wolff, Jennifer

AU - Chen, Chi Chiung Grace

AU - Kruzan, Rachel

AU - Boyd, Cynthia

PY - 2019/5/1

Y1 - 2019/5/1

N2 - PURPOSE: Patients with dementia experience high rates of polypharmacy, potentially inappropriate medication use, and adverse drug events. There is little guidance for clinicians on how to optimize prescribing for this population. Our objective was to investigate clinician-perceived barriers to and facilitators of optimizing prescribing for people with dementia. METHODS: Qualitative study involving semistructured interviews of primary care and specialist clinicians in urban, suburban, and rural settings. Transcripts were analyzed using qualitative content analysis. RESULTS: Interviews were conducted with 12 primary care and 9 specialist clinicians, with a mean (SD) age of 47 (9) and mean (SD) of 14 (10) years in practice. Clinicians cited decisions regarding the following drug classes as particularly challenging: oral anticoagulants, antidiabetic agents, statins, bladder antimuscarinics, and antipsychotics. Perceived enablers of optimizing prescribing included access to interdisciplinary services and guidelines for nondementia illnesses (eg, diabetes) addressing the care of people with dementia. Barriers included the lack of data on efficacy and safety of most medications in people with dementia, difficulty assessing medication effects in an individual patient, and the perception that stopping medications is seen as "giving up." Clinicians used a variety of strategies to discuss risks and benefits of medications with patients and caregivers. CONCLUSIONS: Clinicians identified numerous barriers to and some facilitators of optimizing prescribing in people with dementia. More data are needed on the benefits and harms of stopping medications in this population. Research should also test different approaches for supporting informed decision making about medications by people with dementia and caregivers.

AB - PURPOSE: Patients with dementia experience high rates of polypharmacy, potentially inappropriate medication use, and adverse drug events. There is little guidance for clinicians on how to optimize prescribing for this population. Our objective was to investigate clinician-perceived barriers to and facilitators of optimizing prescribing for people with dementia. METHODS: Qualitative study involving semistructured interviews of primary care and specialist clinicians in urban, suburban, and rural settings. Transcripts were analyzed using qualitative content analysis. RESULTS: Interviews were conducted with 12 primary care and 9 specialist clinicians, with a mean (SD) age of 47 (9) and mean (SD) of 14 (10) years in practice. Clinicians cited decisions regarding the following drug classes as particularly challenging: oral anticoagulants, antidiabetic agents, statins, bladder antimuscarinics, and antipsychotics. Perceived enablers of optimizing prescribing included access to interdisciplinary services and guidelines for nondementia illnesses (eg, diabetes) addressing the care of people with dementia. Barriers included the lack of data on efficacy and safety of most medications in people with dementia, difficulty assessing medication effects in an individual patient, and the perception that stopping medications is seen as "giving up." Clinicians used a variety of strategies to discuss risks and benefits of medications with patients and caregivers. CONCLUSIONS: Clinicians identified numerous barriers to and some facilitators of optimizing prescribing in people with dementia. More data are needed on the benefits and harms of stopping medications in this population. Research should also test different approaches for supporting informed decision making about medications by people with dementia and caregivers.

KW - Adverse Decision Making

KW - Comorbidity

KW - Dementia

KW - Drug Reaction

KW - Geriatrics

KW - Polypharmacy

KW - Potentially Inappropriate Medications

KW - Primary Health Care

KW - Qualitative Research

KW - Risk Assessment

UR - http://www.scopus.com/inward/record.url?scp=85065755898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065755898&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2019.03.180335

DO - 10.3122/jabfm.2019.03.180335

M3 - Article

C2 - 31068402

AN - SCOPUS:85065755898

VL - 32

SP - 383

EP - 391

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 3

ER -